Emergent BioSolutions Inc.
EBS· NYSE
EBSEmergent BioSolutions Inc.
Source filing unavailable
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Revenue | $70.38M | $88.14M | $62.14M |
| Net Income | $7.63M | $14.21M | $9.81M |
| EPS Diluted | $0.21 | $0.39 | $0.31 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Emergent BioSolutions Inc. · CIK 1367644 · Engraved from SEC EDGAR
